Su uso es permitido en deportistas competitivos, a diferencia de BPC-157, TB-500 e IGF-1 que s estn prohibidos
Varkouhi AK, He X, Teixeira Monteiro AP, Amatullah H, Tsoporis JN, Gupta S, et al
Conversely, the same analysis found no difference in weight loss for exenatide once weekly or liraglutide between patients experiencing gastrointestinal adverse events and those with none in DURATION-6 [52]
[12] improves cardiovascular performance and glycemic control
GLP-1 drugs, also known as GLP-1 agonists, stimulate the pancreas to release insulin and suppress glucagon, another hormone that raises blood sugar